Table 2.

Distribution of patients by number of prior treatment failures in EVOLVE studies

	PBO N = 894	GMB 120 mg N = 444	GMB 240 mg N = 435	Overall N = 1773
Prior preventive treatment, %	62.1	65.3	61.8	62.8
Failure of ≥1 medication	24.8	28.8	23.9	25.6
Failure of ≥2 medications	10.3	11.5	10.3	10.6
Failure of ≥2 medication classes	8.6	10.8	9.2	9.3
Failure of ≥3 medications	4.0	6.8	4.1	4.7
Failure of ≥3 medication classes	3.1	6.3	3.0	3.9

GMB, galcanezumab; PBO, placebo.